Summary Italian asthma and COPD patients are generally satisfied with the diagnosis process. A low percentage of patients are dissatisfied with the public authorities and a majority have written management plans. However, very few if any asthma patients use self-management support tools, while a higher percentage of COPD patients feel that their social life suffers due to the disease versus overall national averages. Active Patient ACCESS Report country fact sheet: Italy Highlights are satisifed or very satisfied with the asthma diagnosis process have been to the emergency room within the past 12 months between 1 and 3 times Less concern about the impact of outdoor tobacco smoke (vs. 41% overall) 82% 26% 26% Majority of patients have written management plan (vs. 43% overall) 62% ASTHMA COPD PREVENTION EMPOWERMENT 2 5% 9% 65% initially received wrong diagnosis years between symptoms and COPD diagnosis (vs. 3.4 overall) don't know or ever heard of a Disease Management Programme (DMP) of patients are dissatisfied or very dissatisfied with public authorities #ShowLeadership read full report: https://efanet.online/ACCESS What is the ACCESS report? EFA conducted a survey of 700+ participants in seven countries of patients with asthma, patients with COPD and perceptions in prevention and patient empowerment. This country fact sheet represents further examination of highlights or noted deviations from overall averages. Structure Story Design ASTHMA COPD PREVENTION EMPOWERMENT Care: Nearly 0% use self-management support tools (like e/m health) SABA used less compared to average (45% vs. 62% overall) Spirometry (62% vs. 79% overall), laboratory tests (42% vs. 63% overall), X-xray or CT scan (40% vs. 50% overall), flu vaccination (38% vs. 49% overall), (36% vs. 46% overall) used less than overall averages Perception Only 10% (vs. 34% overall) believe comorbidities influence therapy Care LABA is the main medication and used more than SABA (60% vs. 55% overall) Services used: - Flu vaccination: 65% (vs. 53% overal) - Pneumococcus vaccination: 53% (vs. 37% overall) - Oxygen: 44% (vs. 33% overall) Perception Only 11% (vs 28% overall average) believe comorbidities influence therapy 60% feel that their social life suffers due to the disease (vs. 49% overall) Asthma and COPD action plans are promoted more by public authority more when compared to other countries (39% vs. 29% overall) 70% (vs. 54% overall) receive training on how to inhale from time to time Pulmonologists (81%) and GPs (83%) are the main source of information Friends and relatives are consulted more than in other countries (53% vs. 40% overall). Allergologists (9% vs. 20% overall) and nurses (8% vs. 20% overall) are consulted less Patients have lower access to specialised centres (16% vs. 29% overall) Treatments currently used by patients for their asthma 27% LABA & Cortisone combined 73% Inhaled corticosteroids/Cortisone 27% Antihistamines/antiallergics 40% LABA reliever 45% SABA/emergency relief Treatments currently used by patients for their COPD 49% Smoking cessation 55% SABA/emergency relief 60% LABA rliever 31% Oxygen therapy 42% Combination inhalers w/steroids Active Patient ACCESS Report country fact sheet: Italy #ShowLeadership read full report: https://efanet.online/ACCESS

ACCESS Report Active Patient - efanet.org · Summary Italian asthma and COPD patients are generally satisfied with the diagnosis process. A low percentage of patients are dissatisfied

Download PDF Report

Upload
others
View
0
Download
0

Embed Size (px)

Citation preview

Page 1: ACCESS Report Active Patient - efanet.org · Summary Italian asthma and COPD patients are generally satisfied with the diagnosis process. A low percentage of patients are dissatisfied

Active PatientACCESS Report

country fact sheet: Italy

Highlights

are satisifed or verysatisfied with theasthma diagnosis

process

have been to theemergency roomwithin the past 12months between 1

and 3 times

Less concernabout the impact

of outdoortobacco smoke(vs. 41% overall)

82%

26%

26%Majority of

patients havewritten

management plan(vs. 43% overall)

62%

ASTHMA COPD PREVENTION EMPOWERMENT

5% 9% 65%initially receivedwrong diagnosis

years betweensymptoms andCOPD diagnosis(vs. 3.4 overall)

don't know or everheard of a Disease

ManagementProgramme (DMP)

of patients aredissatisfied or very

dissatisfied withpublic authorities

#ShowLeadershipread full report: https://efanet.online/ACCESS

What is the ACCESS report? EFA conducted a survey of 700+ participants in sevencountries of patients with asthma, patients with COPDand perceptions in prevention and patientempowerment. This country fact sheet representsfurther examination of highlights or noted deviationsfrom overall averages.

Structure Story Design

ASTHMA

COPD

PREVENTION

EMPOWERMENT

Care: Nearly 0% use self-management support tools(like e/m health)SABA used less compared to average (45% vs.62% overall)Spirometry (62% vs. 79% overall), laboratory tests(42% vs. 63% overall), X-xray or CT scan (40% vs.50% overall), flu vaccination (38% vs. 49%overall), (36% vs. 46% overall) used less thanoverall averages

PerceptionOnly 10% (vs. 34% overall) believe comorbiditiesinfluence therapy

CareLABA is the main medication and used more thanSABA (60% vs. 55% overall)Services used: - Flu vaccination: 65% (vs. 53% overal)

- Pneumococcus vaccination: 53% (vs. 37% overall) - Oxygen: 44% (vs. 33% overall)

PerceptionOnly 11% (vs 28% overall average) believecomorbidities influence therapy60% feel that their social life suffers due to thedisease (vs. 49% overall)

Asthma and COPD action plans are promoted more by public authority morewhen compared to other countries (39% vs. 29% overall)

70% (vs. 54% overall) receive training on how to inhale from time to timePulmonologists (81%) and GPs (83%) are the main source of informationFriends and relatives are consulted more than in other countries (53% vs. 40%overall). Allergologists (9% vs. 20% overall) and nurses (8% vs. 20% overall) areconsulted lessPatients have lower access to specialised centres (16% vs. 29% overall)

Treatments currently usedby patients for their asthma

27%LABA & Cortisone combined

73%Inhaled corticosteroids/Cortisone

27%Antihistamines/antiallergics

40%LABA reliever

45%SABA/emergency relief

Treatments currently usedby patients for their COPD

49%Smoking cessation

55%SABA/emergency relief

60%LABA rliever

31%Oxygen therapy

42%Combination inhalers w/steroids